Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Summerskill

Gut

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Gut|June 1, 1978
Aguecheek's diseaseW H Summerskill
Gut|December 1, 1978
Oral prednisone for chronic active liver disease: dose responses and bioavailability studiesM Uribe, S W Schalm, W H Summerskill, et al.
Gut|November 1, 1975
Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine comparedW H Summerskill, M G Korman, H V Ammon, et al.
Gut|January 1, 1970
Measurement of gastrointestinal transmural electric potential difference in manM G Geall, C F Code, D C McIlrath, et al.
Gut|October 1, 1976
Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigenS W Schalm, W H Summerskill, G L Gitnick, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Gut|June 1, 1978
Aguecheek's diseaseW H Summerskill
Gut|December 1, 1978
Oral prednisone for chronic active liver disease: dose responses and bioavailability studiesM Uribe, S W Schalm, W H Summerskill, et al.
Gut|November 1, 1975
Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine comparedW H Summerskill, M G Korman, H V Ammon, et al.
Gut|January 1, 1970
Measurement of gastrointestinal transmural electric potential difference in manM G Geall, C F Code, D C McIlrath, et al.
Gut|October 1, 1976
Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigenS W Schalm, W H Summerskill, G L Gitnick, et al.
Pageof 1